Entrepreneur. Scientist. Contrarian. One of the most misunderstood figures in modern America deserves a second look — and a pardon.
Sign the PetitionMartin Shkreli built his first hedge fund before most people finish college. He founded multiple pharmaceutical companies, pioneered rare disease drug development, and livestreamed his work with a transparency that Wall Street never expected. He was also convicted of securities fraud in 2017 — a conviction his supporters argue was driven by media hysteria, not justice.
Since his release, Shkreli has returned to pharmaceutical research, launched a drug company focused on rare diseases, and engaged openly with the public. He has shown more accountability than most executives who face far fewer consequences for far worse behavior.
A presidential pardon would not erase accountability — it would restore a man who has already paid his debt, continues to contribute, and whose prosecution was colored by one of the most relentless public vilification campaigns in modern memory.
Add your name to the growing list of Americans who believe Martin Shkreli deserves a presidential pardon.
Interviews, podcasts, and YouTube appearances — unfiltered.
How Shkreli turned $2M into $1B in pharma, the Daraprim story, prison, and what comes next.
Watch →Martin's own show — markets, medicine, biotech, and unfiltered commentary. New episodes regularly.
Watch →Hours of pharmaceutical breakdowns, market analysis, and unfiltered commentary.
Watch →Shkreli on his prosecution, the Hillary joke, prison, and Sam Bankman-Fried.
Watch →Regular X Spaces appearances discussing biotech, politics, and current events.
Follow →Post-release interview on pharmaceutical pricing, innovation, and the future of drug development.
Read →Loading latest coverage…